NUCELL TX SR

About

NUCELL TX SR contains Tranexamic Acid in a sustained-release formulation. Tranexamic acid is an antifibrinolytic agent that works by reversibly binding to plasminogen, thereby preventing its conversion to plasmin. Plasmin is an enzyme responsible for breaking down fibrin clots, which are essential for stopping bleeding. By inhibiting plasmin, tranexamic acid stabilizes blood clots and reduces excessive bleeding. The sustained-release formulation ensures a prolonged therapeutic effect, maintaining consistent drug levels in the body.

This medication is primarily used to manage and prevent excessive bleeding in various clinical situations, including heavy menstrual bleeding (menorrhagia), post-surgical bleeding, and in conditions where fibrinolysis is increased. Its mechanism of action makes it effective in reducing blood loss and the need for blood transfusions, improving patient outcomes. The SR formulation enhances patient compliance by reducing dosing frequency.

Uses

• Heavy menstrual bleeding (menorrhagia)
• Prevention of bleeding in dental procedures (hemophiliacs)
• Post-surgical bleeding
• Hereditary angioedema

Directions For Use

Take the tablet whole with water, as directed by your physician. Do not crush or chew.

Benefits

• Reduces excessive bleeding
• Stabilizes blood clots
• Effective for heavy menstrual bleeding
• Sustained-release for prolonged action
• Reduces need for blood transfusions
• Improves quality of life for menorrhagia

Side Effects

• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Headache
• Dizziness
• Back pain
• Muscle cramps
• Allergic skin reactions
• Visual disturbances (rare)
• Thromboembolic events (rare)
• Hypotension (with rapid IV administration)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally fine, but excessive intake may exacerbate gastrointestinal side effects.
• Pregnancy - Use with caution and only if clearly needed, after consulting a doctor. Limited data available.
• Breastfeeding - Tranexamic acid is excreted in breast milk. Use is generally not recommended during breastfeeding.
• Liver - Use with caution in patients with liver impairment; dose adjustment may be necessary.
• Kidney - Contraindicated in severe renal impairment. Dose adjustment is required for moderate impairment.
• Lung - Use with caution in patients with a history of thromboembolic disease, including pulmonary embolism.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.